Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Sell
12,062
-106
-0.9% -$2.77K 0.28% 77
2026
Q1
$342K Sell
12,168
-2,161
-15% -$57.5K 0.38% 53
2025
Q4
$357K Buy
14,329
+447
+3% +$11.3K 0.36% 60
2025
Q3
$354K Buy
+13,882
New +$343K 0.36% 54

Other funds holding PFE

J. Team Financial's PFE Position: Q2 2026 in Review

J. Team Financial reduced its Pfizer (PFE) stake by 0.87% in Q2 2026, selling an estimated $2.77K and leaving 12,062 shares worth $290K. The position accounts for 0.28% of the portfolio, ranked #77.

J. Team Financial first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $357K in Q4 2025. 1,707 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • J. Team Financial held 12,062 shares of Pfizer worth $290K as of Q2 2026.
  • J. Team Financial sold 106 Pfizer shares in Q2 2026, an estimated $2.77K.
  • Pfizer made up 0.28% of J. Team Financial's portfolio in Q2 2026, its #77 holding.
  • J. Team Financial first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • J. Team Financial's Pfizer position peaked at $357K in Q4 2025.
  • 1,707 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on J. Team Financial's 13F filing for Q2 2026, filed 27 Jul 2026.